Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) EBIT (2016 - 2025)

Ultralife (ULBI) has 15 years of EBIT data on record, last reported at -$951000.0 in Q3 2025.

  • For Q3 2025, EBIT fell 286.11% year-over-year to -$951000.0; the TTM value through Sep 2025 reached $6.2 million, down 49.11%, while the annual FY2024 figure was $10.0 million, 5.17% up from the prior year.
  • EBIT reached -$951000.0 in Q3 2025 per ULBI's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, EBIT topped out at $4.1 million in Q1 2024 and bottomed at -$951000.0 in Q3 2025.
  • Average EBIT over 4 years is $2.0 million, with a median of $2.1 million recorded in 2023.
  • Peak YoY movement for EBIT: skyrocketed 15526.92% in 2024, then tumbled 286.11% in 2025.
  • A 4-year view of EBIT shows it stood at $1.1 million in 2021, then surged by 241.03% to $3.6 million in 2023, then crashed by 59.61% to $1.5 million in 2024, then tumbled by 164.52% to -$951000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$951000.0 in Q3 2025, $2.3 million in Q2 2025, and $3.4 million in Q1 2025.